Certified by Founder
Lodge
Mozart Therapeutics, Inc
start up
United States
- Seattle, WA
- 08/06/2023
- Series A
- $25,000,000
Mozart is developing disease-modifying therapies for autoimmune and inflammatory diseases that work by targeting a novel regulatory immune pathway.
- Industry Biotechnology Research
- Website https://www.mozart-tx.com/
- LinkedIn https://www.linkedin.com/company/mozart-therapeutics/